Salt Lake, Utah (UT) In Vitro and In Vivo Diagnostic Substances Companies

Featured companies
3PDx
615 Arapeen Drive
Salt Lake City UT 84108
(801) 587-0363
3pdx LLC
2007 East Kensington Avenue
Salt Lake City UT 84108
(801) 703-5157
Guanine Inc
825 North 300 West # C325
Salt Lake City UT 84103
(801) 792-7074
Not satisfied? Select a reasonRate this pageSend feedback

Or try our search form or quick navigation by category and location

Contradyn Inc
615 South Arapeen Drive # 102
Salt Lake City UT 84108
(801) 582-5400
Immviz
615 South Arapeen Drive # 310
Salt Lake City UT 84108
(801) 581-7792
Knudra Diagnostics
2500 South State St.
Salt Lake City UT 84115
(385) 202-3854
Vestan Inc
615 South Arapeen Drive # 110
Salt Lake City UT 84108
(801) 983-6448
Porter Diagnostics LLC
615 South Arapeen Drive
Salt Lake City UT 84108
(801) 831-4282
Volu-Sol
5095 West 2100 South
Salt Lake City UT 84120
(800) 821-2495

Volu-Sol
Baxter Healthcare Corporation
6864 South 300 West
Midvale UT 84047
(801) 565-6100
Fulcrum Bioscience LLC
1567 West Marty Circle
West Jordan UT 84084
(801) 792-0652
Cardio Risk
912 West Baxter Drive
South Jordan UT 84095
(801) 432-8109
Inertia
11581 Woodhampton Dr.
Sandy UT 84092
(801) 859-8141
Inertia
11581 South Woodhampton Drive
Sandy UT 84092
(801) 859-8141
Whereorg has 16 results under In Vitro and In Vivo Diagnostic Substances Companies in Salt Lake.

Narrow down the browsing criteria below to see more companies.

Select a location for category In Vitro and In Vivo Diagnostic Substances


Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020